Condition

Stroke Acute (3)

Heart Failure (1)

Infectious Diseases (1)

Posterior Circulation Brain Infarction (1)

Respiratory Insufficiency (1)

Rheumatic Diseases (1)

Stroke Ischemic (1)

TBI (Traumatic Brain Injury) (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Phase

phase 3 (1)

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)

Janssen Research & Development, LLC (1)

University of Thessaly (1)

Collaborator

A.O. Ospedale Papa Giovanni XXIII (1)

Azienda Ospedaliera Citta della Salute e della Scienza di Torino (1)

Azienda Ospedaliera San Gerardo di Monza (1)

Azienda Ospedaliero, Universitaria Pisana (1)

Bayer (1)

Fondazione IRCCS Policlinico San Matteo di Pavia (1)

Fondazione Poliambulanza Istituto Ospedaliero (1)

Universita degli Studi di Brescia (1)

University of Lausanne (1)

Intervention

astral prognostic score (1)

placebo (1)

posttraumatic cerebral infarction (1)

rivaroxaban, 10 mg (1)

rivaroxaban, 7.5 mg (1)

Study Documents

Intervention Type

diagnostic test (1)

drug (1)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

stroke acute

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Posterior Circulation ASTRAL Prognostic Score

Active, not recruiting

Stroke Ischemic
+2 more

ASTRAL prognostic score

Larissa, Thessaly, Greece
+1 more

Jun 6, 2023

Heart Failure, Respiratory Insufficiency, Stroke Acute Trial in Worldwide (Rivaroxaban, 10 mg, Rivaroxaban, 7.5 mg, Placebo)

Completed

Has Results

Heart Failure
+4 more

Rivaroxaban, 10 mg
+2 more

Birmingham, Alabama
+616 more

Nov 5, 2019

The Multicenter Italian INCEPT Study

Completed

TBI (Traumatic Brain Injury)
Stroke Acute

posttraumatic cerebral infarction

Brescia, Italy

Azienda Ospedaliera Spedali Civili di Brescia

Apr 27, 2015